Institut de Neurociències (INc) and Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain.
Hand and Peripheral Nerve Unit, Hospital Clínic i Provincial, Universitat de Barcelona, Barcelona, Spain.
Sci Rep. 2017 Sep 20;7(1):12028. doi: 10.1038/s41598-017-11086-3.
The "gold standard" treatment of patients with spinal root injuries consists of delayed surgical reconnection of nerves. The sooner, the better, but problems such as injury-induced motor neuronal death and muscle atrophy due to long-term denervation mean that normal movement is not restored. Herein we describe a preclinical model of root avulsion with delayed reimplantation of lumbar roots that was used to establish a new adjuvant pharmacological treatment. Chronic treatment (up to 6 months) with NeuroHeal, a new combination drug therapy identified using a systems biology approach, exerted long-lasting neuroprotection, reduced gliosis and matrix proteoglycan content, accelerated nerve regeneration by activating the AKT pathway, promoted the formation of functional neuromuscular junctions, and reduced denervation-induced muscular atrophy. Thus, NeuroHeal is a promising treatment for spinal nerve root injuries and axonal regeneration after trauma.
脊髓根损伤患者的“金标准”治疗方法包括延迟手术重新连接神经。时间越早越好,但由于长期失神经导致的损伤诱导的运动神经元死亡和肌肉萎缩等问题意味着无法恢复正常运动。在这里,我们描述了一种腰椎神经根撕裂的临床前模型,该模型用于建立一种新的辅助药物治疗方法。使用系统生物学方法确定的新药治疗组合NeuroHeal 的慢性治疗(长达 6 个月)可发挥持久的神经保护作用,减少神经胶质增生和基质蛋白聚糖含量,通过激活 AKT 通路加速神经再生,促进功能性神经肌肉接头的形成,并减少失神经引起的肌肉萎缩。因此,NeuroHeal 是治疗脊髓神经根损伤和创伤后轴突再生的一种很有前途的方法。